News

  • PPD is currently looking to recruit a Scientist to be based in our cGMP Lab in Athlone, Ireland. The basic purpose of the Scientist role is to perform a variety of complex sample preparation and… Read more . . .

  • QVA149 developers Vectura and Sosei have confirmed that Novartis has submitted an application for Japanese approval of the inhaled fixed dose combination of indacaterol maleate and glycopyrronium bromide for the treatment of COPD. Novartis, which… Read more . . .

  • Submit 500 word abstracts by December 14, 2012 online at Read more . . .

  • Boehringer Ingelheim has announced an €85 million expansion to the BI microParts GmbH inhaler manufacturing facililty in Dortmund, Germany meant to double its annual production of Respimat inhalers to 44 million by 2015. Filling of… Read more . . .

  • The FDA has issued a warning to parents and health care professionals after receiving reports of accidental ingestion of nasal sprays and eye drops by children. According to the agency, the decongestant nasal sprays reported… Read more . . .

  • Two companies that provide services to OINDP developers and manufacturers have been awarded major prizes recently. The 2012 British Engineering Excellence Awards recognized device design experts Team Consulting as “Consultancy of the Year.” Criteria for… Read more . . .

  • Pharmaxis’s Bronchitol mannitol dry powder for inhalation has become the first treatment for cystic fibrosis to receive a positive recommendation from he UK National Institute for Health and Clinical Excellence (NICE), according to the company.… Read more . . .

  • Northern California. The Senior Process Engineer is a lead member of the Process Development and Manufacturing team developing spray drying and micronization processes at pilot and commercial scales. Supervise the manufacturing team during manufacturing campaigns.… Read more . . .

  • Novartis has filed a marketing application with the EMA for its QVA149 indacaterol maleate/glycopyrronium bromide DPI for the treatment of COPD. The filing triggered milestone payments of $5 million each to the drug’s developers, Vectura… Read more . . .

  • According to the Associated Press, GlaxoSmithKline is extending its “Complete the Cycle” inhaler recycling program to 31 US cities, which were chosen because they account for about a third of all inhaler sales in the… Read more . . .

May 10-May 14RDD 2026, Phoenix, AZ, USA

May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA

May 17-May 20: ATS International Conference 2026, Orlando, FL, USA

June 10SMI.London 2026, London, UK

July 13-July 162026 ISAM Congress, Taipei, Taiwan